<SEC-DOCUMENT>0001104659-18-010931.txt : 20180221
<SEC-HEADER>0001104659-18-010931.hdr.sgml : 20180221
<ACCEPTANCE-DATETIME>20180221070826
ACCESSION NUMBER:		0001104659-18-010931
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20180216
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20180221
DATE AS OF CHANGE:		20180221

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BRUKER CORP
		CENTRAL INDEX KEY:			0001109354
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				043110160
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30833
		FILM NUMBER:		18627036

	BUSINESS ADDRESS:	
		STREET 1:		40 MANNING RD
		CITY:			BILLERICA
		STATE:			MA
		ZIP:			01821
		BUSINESS PHONE:		978663-3660

	MAIL ADDRESS:	
		STREET 1:		40 MANNING RD
		CITY:			BILLERICA
		STATE:			MA
		ZIP:			01821

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BRUKER BIOSCIENCES CORP
		DATE OF NAME CHANGE:	20030721

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BRUKER DALTONICS INC
		DATE OF NAME CHANGE:	20000315
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a18-6558_18k.htm
<DESCRIPTION>8-K
<TEXT>


<html>
<head>



  </head>
<body link=blue lang="EN-US">
<div style="font-family:Times New Roman;">
<div style="border-bottom:solid windowtext 1.0pt;border-left:none;border-right:none;border-top:solid windowtext 3.0pt;padding:1.0pt 0in 1.0pt 0in;">
<p style="border:none;margin:0in 0in .0001pt;padding:0in;"><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
</div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">UNITED STATES<br> SECURITIES AND EXCHANGE COMMISSION<br>  </font>Washington, DC 20549</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center" style="margin:0in 0in .0001pt;text-align:center;"><hr size="1" width="25%" noshade align="center" style="color:black;"></div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">FORM&nbsp;8-K</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">CURRENT REPORT<br>  </font></b><b><font size="3" style="font-size:12.0pt;font-weight:bold;">Pursuant to Section&nbsp;13 OR 15(d)<br> of the Securities Exchange Act of 1934</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center" style="margin:0in 0in .0001pt;text-align:center;"><hr size="1" width="25%" noshade align="center" style="color:black;"></div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date of Report (Date of earliest event reported): <b>February&nbsp;16, 2018</b></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">BRUKER CORPORATION <br>  </font></b>(Exact name of registrant as specified in its charter)</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center">
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Delaware<br>    </font></b>(State or other jurisdiction<br>   of incorporation)</p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">000-30833<br>    </font></b>(Commission<br>   File Number)</p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">04-3110160</font></b><br>   (IRS Employer<br>   Identification No.)</p>    </td>   </tr>
<tr>
<td width="100%" colspan="5" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">40   Manning Road<br>   Billerica, MA 01821<br>    </font></b>(Address of principal executive offices)(Zip Code)</p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="5" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt 13.75pt;text-align:center;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Registrant&#146;s telephone number, including area code: <b>(978)&nbsp;663-3660</b></font></p>    </td>   </tr>  </table>
</div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Check the appropriate box if the Form&nbsp;8-K filing is intended to simultaneously satisfy the reporting obligation of the registrant under any of the following provisions:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font>&#160;&#160;&#160;&#160; Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font>&#160;&#160;&#160;&#160; Soliciting material pursuant to Rule&nbsp;14a-12 of the Exchange Act (17 CFR 240.14a-12)</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font>&#160;&#160;&#160;&#160; Pre-commencement communications pursuant to Rule&nbsp;14d-2(b)&nbsp;under the Exchange Act (17 CFR 240.14d-2(b))</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font>&#160;&#160;&#160;&#160; Pre-commencement communications pursuant to Rule&nbsp;13e-4(c)&nbsp;under the Exchange Act (17 CFR 240.13e-4(c))</p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule&nbsp;405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule&nbsp;12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2).</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Emerging growth company&#160; </font><font face="Wingdings">o</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;13(a)&nbsp;of the Exchange Act. </font><font face="Wingdings">o</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="border-bottom:solid windowtext 3.0pt;border-left:none;border-right:none;border-top:solid windowtext 1.0pt;padding:1.0pt 0in 1.0pt 0in;">
<p style="border:none;margin:0in 0in .0001pt;padding:0in;"><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
</div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\107899\18-6558-1\task8747690\6558-1-ba.htm',USER='107899',CD='Feb 21 07:54 2018' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 5.02</font></b>&#160;&#160;&#160; <b>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; On February&nbsp;16, 2018, Mr.&nbsp;Anthony L. Mattacchione, Chief Financial Officer (CFO) and Senior Vice President of Bruker Corporation (&#147;Bruker,&#148; the &#147;Company,&#148; &#147;we&#148; or &#147;us&#148;), submitted his resignation, effective as of March&nbsp;16, 2018, in order to pursue other interests. Mr.&nbsp;Mattacchione, who has served as the Company&#146;s principal financial officer since 2015 and principal accounting officer since 2016, informed us that he has accepted a position as Chief Financial Officer of Albany Molecular Research,&nbsp;Inc., and will commence service in that position in April&nbsp;2018. Mr.&nbsp;Mattacchione&#146;s resignation is not the result of any dispute or disagreement with the Company or any matter relating to the Company&#146;s accounting practices or financial statements.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mr.&nbsp;Mattacchione is expected to continue in his role as CFO and principal financial officer until his departure, and he will work during the next few weeks to ensure an orderly transition of his responsibilities. Bruker intends to initiate a search for Mr.&nbsp;Mattacchione&#146;s successor and expects to appoint an interim Chief Financial Officer within weeks. Effective as of February&nbsp;16, 2018, Mr.&nbsp;Mattacchione ceased to serve as the Company&#146;s principal accounting officer and is succeeded in that role by Gerald Herman, Vice President and Corporate Controller, as further described below.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; On February&nbsp;16, 2018, the Company appointed Gerald N. Herman, age 60, to serve as the Company&#146;s principal accounting officer. Mr.&nbsp;Herman assumes the role of principal accounting officer from Mr.&nbsp;Mattacchione, effective February&nbsp;16, 2018. Mr.&nbsp;Herman joined the Company in December&nbsp;2016 as Vice President and Corporate Controller and will continue to serve in that capacity following this appointment.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Prior to joining the Company, Mr.&nbsp;Herman served as Corporate Vice President - Clinical Operations of PAREXEL International from 2014 to February&nbsp;2016 and as Corporate Vice President&nbsp;&amp; Controller-Finance of PAREXEL from 2008 to 2013. From 2005 to 2008, Mr.&nbsp;Herman was Vice President-Corporate Controller of Presstek,&nbsp;Inc. Prior to 2005, he served in a variety of financial and accounting roles at various organizations, including as Senior Manager at Arthur Andersen LLP from 1979 to 1987. Mr.&nbsp;Herman is a Certified Public Accountant in the Commonwealth of Massachusetts and holds a M.B.A. from the University of Chicago and a Master of Science in Taxation from Bentley University.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">There is no arrangement or understanding between Mr.&nbsp;Herman and any other person pursuant to which Mr.&nbsp;Herman was appointed as an officer of the Company. There are no transactions in which Mr.&nbsp;Herman has an interest requiring disclosure under Item 404(a)&nbsp;of Regulation S-K. Mr.&nbsp;Herman receives a base salary comparable to other employees of the Company at his level, and is eligible to participate in the Company&#146;s employee compensation or benefit plans and programs as may be generally made available to other Company employees at his level.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A copy of the Company&#146;s press release is attached as Exhibit&nbsp;99.1 to this Current Report on Form&nbsp;8-K.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 9.01&#160; Financial Statements and Exhibits.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="82%" style="border-collapse:collapse;margin-left:5.4pt;width:82.22%;">
<tr style="page-break-inside:avoid;">
<td width="5%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:5.78%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(d)</font></b></p>    </td>
<td width="94%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:94.22%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibits</font></b></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="94%" style="border-collapse:collapse;margin-left:31.5pt;">
<tr>
<td width="8%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:8.86%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Number</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.64%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="88%" valign="bottom" style="padding:0in 0in 0in 0in;width:88.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="8%" valign="top" style="padding:0in 0in 0in 0in;width:8.86%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.64%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="88%" valign="top" style="padding:0in 0in 0in 0in;width:88.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="8%" valign="top" style="padding:0in 0in 0in 0in;width:8.86%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">99.1</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.64%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="88%" valign="top" style="padding:0in 0in 0in 0in;width:88.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="a18-6558_1ex99d1.htm#Exhibit99_1_075219" title="Click to goto ">Press release dated February&nbsp;21, 2018.</a></font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="PB_2_071959_3199"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='2',FILE='C:\JMS\107899\18-6558-1\task8747690\6558-1-ba.htm',USER='107899',CD='Feb 21 07:54 2018' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SIGNATURES</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:20.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">BRUKER CORPORATION <br>   (Registrant)</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 12.25pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date:   February&nbsp;21, 2018</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/Anthony L.   Mattacchione </font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Anthony   L.Mattacchione <br>    <i>Chief Financial Officer and <br>   Senior Vice President</i></font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">3<a name="PB_3_072431_7056"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='3',FILE='C:\JMS\107899\18-6558-1\task8747690\6558-1-ba.htm',USER='107899',CD='Feb 21 07:54 2018' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a18-6558_1ex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>


<html>
<head>



  </head>
<body link=blue lang="EN-US">
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 99.1<a name="Exhibit99_1_075219"></a></font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman"><img width="203" height="105" src="g65581mmi001.jpg"></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Bruker Announces Resignation of Chief Financial Officer and Appointment of Principal Accounting Officer</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">BILLERICA, Massachusetts</font></b> &#151; <b>February&nbsp;21, 2018</b> &#151; Bruker Corporation (NASDAQ: BRKR) today announced that Mr.&nbsp;Anthony L. Mattacchione, Chief Financial Officer (CFO) and Senior Vice President of Bruker, has submitted his resignation, effective as of March&nbsp;16, 2018, in order to pursue other interests. &#160;Mr.&nbsp;Mattacchione has informed us that he has accepted a position as Chief Financial Officer of private-equity backed CDMO company Albany Molecular Research,&nbsp;Inc., commencing in April&nbsp;2018.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mr.&nbsp;Mattacchione&#146;s resignation is not the result of any dispute or disagreement with the Company, or any matter relating to the Company&#146;s accounting practices or financial statements.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mr.&nbsp;Mattacchione is expected to continue in his role as Bruker&#146;s Chief Financial Officer until his departure from the Company, and he will work during the next few weeks to ensure an orderly transition of his responsibilities.&#160; Bruker intends to initiate a search for Mr.&nbsp;Mattacchione&#146;s permanent successor.&#160; Moreover, Bruker expects to appoint an interim Chief Financial Officer within weeks.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Bruker today also announced the appointment of Gerald N. Herman to serve as Bruker&#146;s principal accounting officer (&#145;PAO&#146;), effective immediately.&#160; Mr.&nbsp;Herman joined Bruker in December&nbsp;2016 as Vice President and Corporate Controller, and will continue to serve in that capacity following this PAO appointment.&#160; Mr.&nbsp;Herman previously has served in senior executive positions with various publicly traded companies, including as Corporate Vice President - Clinical Operations of PAREXEL International from 2014 to February&nbsp;2016, and as Corporate Vice President&nbsp;&amp; Controller-Finance of PAREXEL from 2008 to 2013.&#160; Prior to 2008, Mr.&nbsp;Herman was Vice President-Corporate Controller of Presstek,&nbsp;Inc. and also served in financial, consulting and accounting roles at various organizations, including as Senior Manager at Arthur Andersen LLP from 1979 to 1987.&#160; Mr.&nbsp;Herman is a Certified Public Accountant and holds a MBA degree from the University of Chicago, and a Master of Science in Taxation from Bentley University.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Frank H. Laukien, Bruker&#146;s President and CEO, commented: &#147;I would like to thank Tony for doing an outstanding job as our Chief Financial Officer over the last 3 years, and for his service to Bruker since joining us in 2013.&#160; We are grateful for Tony&#146;s positive impact on Bruker, and wish him continued success.&#148;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dr.&nbsp;Laukien continued: &#147;Bruker&#146;s financial guidance for 2018 remains unchanged, and our commitment to continued, multi-year profitable growth is not affected.&#160; Bruker has developed solid</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\107899\18-6558-1\task8747690\6558-1-mm.htm',USER='107899',CD='Feb 21 07:52 2018' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">management processes, has an experienced executive leadership team, and our finance management team has great depth and expertise.&#148;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mr.&nbsp;Mattacchione said: &#147;I am very proud of my accomplishments with Bruker over the last five years, including three years as its CFO. During this time, we completed Bruker&#146;s operational transformation and generated meaningful shareholder value. I believe Bruker is well-positioned to continue to create value for years to come.&#148;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">About Bruker Corporation (NASDAQ: BRKR)</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">For more than 55 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker&#146;s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research, microbiology and molecular pathology research. For more information, please visit: www.bruker.com .</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"># # #</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Contact</font></u></b><b>:</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Miroslava Minkova</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Head of Investor Relations</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Bruker Corporation</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">T: +1 (978) 663 &#151; 3660, ext. 1479</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">E: miroslava.minkova@bruker.com</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\107899\18-6558-1\task8747690\6558-1-mm.htm',USER='107899',CD='Feb 21 07:52 2018' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g65581mmi001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g65581mmi001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" !I ,L# 2(  A$! Q$!_\0
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MCNA7A)VV?9FI1249K(V"BJU_J=IID'G7MQ'"GJYZ_2N+U?XG0QDQZ3;F8_\
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M#!J5PUPD;;DBCC &[IG ')H UO@__P E'L/]R3_T$UTO[0'_ "%=&_ZXR?\
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MU*RLA**6B@8E!&001D&EHH P=6\&Z5JYW20^3)_?A 4GZ\<US%W\*VW$V>H
MKV$R?U%>BT5O#$U8:)G/4PM*IJT>7#X=:];G]Q>0\=-LK+_2G?\ "!^)9OEE
MOD"_[4[&O3Z*U^O5?+[C+ZA2\_O..\.?#^#2+I+R\F^TW"'*@+\BGUYZFNPI
;:*YJE251WDSIITHTERQ0E+114&@4444 ?__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
